Sugarloaf Wealth Management’s Lennar Class A LEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$22.4K Hold
169
﹤0.01% 387
2024
Q3
$30.7K Hold
169
0.01% 361
2024
Q2
$24.6K Hold
169
0.01% 371
2024
Q1
$28.2K Hold
169
0.01% 363
2023
Q4
$24.4K Hold
169
0.01% 369
2023
Q3
$18.4K Hold
169
﹤0.01% 392
2023
Q2
$20.6K Buy
169
+35
+26% +$3.82K ﹤0.01% 383
2023
Q1
$13.7K Buy
134
+50
+60% +$4.83K ﹤0.01% 441
2022
Q4
$7.33K Hold
84
﹤0.01% 521
2022
Q3
$7K Hold
84
﹤0.01% 570
2022
Q2
$6K Hold
84
﹤0.01% 587
2022
Q1
$7K Hold
84
﹤0.01% 526
2021
Q4
$9K Hold
84
﹤0.01% 521
2021
Q3
$8K Hold
84
﹤0.01% 541
2021
Q2
$8K Buy
84
+83
+8,300% +$8.02K ﹤0.01% 527
2021
Q1
$8 Sell
1
-83
-99% -$6.98K ﹤0.01% 523
2020
Q4
$6K Hold
84
﹤0.01% 530
2020
Q3
$7K Hold
84
﹤0.01% 485
2020
Q2
$5K Hold
84
﹤0.01% 522
2020
Q1
$3K Hold
84
﹤0.01% 569
2019
Q4
$5K Buy
+84
New +$4.79K ﹤0.01% 544

Other funds holding LEN

Sugarloaf Wealth Management's LEN Position: Q4 2024 in Review

Sugarloaf Wealth Management held its Lennar Class A (LEN) position steady in Q4 2024 at 169 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

Sugarloaf Wealth Management first reported a position in LEN in Q4 2019 and has held it in 21 quarters since. The position peaked at $30.7K in Q3 2024. 1,019 funds tracked by Wall St. Rank hold LEN as of Q4 2024.

  • Sugarloaf Wealth Management held 169 shares of Lennar Class A worth $22.4K as of Q4 2024.
  • Sugarloaf Wealth Management left its Lennar Class A share count unchanged in Q4 2024.
  • Lennar Class A made up ﹤0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #387 holding.
  • Sugarloaf Wealth Management first reported a position in Lennar Class A in Q4 2019 and has held it in 21 quarters since.
  • Sugarloaf Wealth Management's Lennar Class A position peaked at $30.7K in Q3 2024.
  • 1,019 funds tracked by Wall St. Rank held Lennar Class A as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.